DORADA adherence study: full view into RebiSmart subdomains parameters in multiple sclerosis treatment.

CONCLUSION: These findings are in line with the potential benefits of RebiSmart to treatment adherence. They demonstrate an overall, very good perception of the device by patients and its individual functions. PMID: 33538199 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33538199?dopt=Abstract

Source: Current Medical Research and Opinion - February 6, 2021 Category: Research Tags: Curr Med Res Opin Source Type: research